154 related articles for article (PubMed ID: 38769209)
1. Sex-specific association of serum dehydroepiandrosterone and its sulfate levels with osteoporosis in type 2 diabetes.
Li S; Li W; Chang L; Wan J; Chen S; Zhang X; He Q; Liu M
J Bone Miner Metab; 2024 May; 42(3):361-371. PubMed ID: 38769209
[TBL] [Abstract][Full Text] [Related]
2. Low Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate Are Associated With Coronary Heart Disease in Men With Type 2 Diabetes Mellitus.
Zhang X; Xiao J; Liu T; He Q; Cui J; Tang S; Li X; Liu M
Front Endocrinol (Lausanne); 2022; 13():890029. PubMed ID: 35832423
[TBL] [Abstract][Full Text] [Related]
3. Low Serum Dehydroepiandrosterone Is Associated With Diabetic Kidney Disease in Men With Type 2 Diabetes Mellitus.
Zhang X; Xiao J; Li X; Cui J; Wang K; He Q; Liu M
Front Endocrinol (Lausanne); 2022; 13():915494. PubMed ID: 35784547
[TBL] [Abstract][Full Text] [Related]
4. Serum DHEA and Its Sulfate Are Associated With Incident Fall Risk in Older Men: The MrOS Sweden Study.
Ohlsson C; Nethander M; Karlsson MK; Rosengren BE; Ribom E; Mellström D; Vandenput L
J Bone Miner Res; 2018 Jul; 33(7):1227-1232. PubMed ID: 29528519
[TBL] [Abstract][Full Text] [Related]
5. The association between serum dehydroepiandrosterone Sulphate (DHEA-S) level and bone mineral density in Korean men.
Lee D; Kim H; Ahn SH; Lee SH; Bae SJ; Kim EH; Kim HK; Choe JW; Kim BJ; Koh JM
Clin Endocrinol (Oxf); 2015 Aug; 83(2):173-9. PubMed ID: 25692973
[TBL] [Abstract][Full Text] [Related]
6. The effects of cortisol and adrenal androgen on bone mass in Asians with and without subclinical hypercortisolism.
Ahn SH; Kim JH; Cho YY; Suh S; Kim BJ; Hong S; Lee SH; Koh JM; Song KH
Osteoporos Int; 2019 May; 30(5):1059-1069. PubMed ID: 30719548
[TBL] [Abstract][Full Text] [Related]
7. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
[TBL] [Abstract][Full Text] [Related]
8. Serum dehydroepiandrosterone levels are associated with lower risk of type 2 diabetes: the Rotterdam Study.
Brahimaj A; Muka T; Kavousi M; Laven JS; Dehghan A; Franco OH
Diabetologia; 2017 Jan; 60(1):98-106. PubMed ID: 27771738
[TBL] [Abstract][Full Text] [Related]
9. Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens.
Jankowski CM; Gozansky WS; Kittelson JM; Van Pelt RE; Schwartz RS; Kohrt WM
J Clin Endocrinol Metab; 2008 Dec; 93(12):4767-73. PubMed ID: 18812486
[TBL] [Abstract][Full Text] [Related]
10. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial.
Jankowski CM; Gozansky WS; Schwartz RS; Dahl DJ; Kittelson JM; Scott SM; Van Pelt RE; Kohrt WM
J Clin Endocrinol Metab; 2006 Aug; 91(8):2986-93. PubMed ID: 16735495
[TBL] [Abstract][Full Text] [Related]
11. The pathophysiological implications of circulating androgens on bone mineral density in a normal female population.
Zofková I; Bahbouh R; Hill M
Steroids; 2000 Dec; 65(12):857-61. PubMed ID: 11077083
[TBL] [Abstract][Full Text] [Related]
12. Endogenous DHEAS Is Causally Linked With Lumbar Spine Bone Mineral Density and Forearm Fractures in Women.
Quester J; Nethander M; Eriksson A; Ohlsson C
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2080-e2086. PubMed ID: 34935937
[TBL] [Abstract][Full Text] [Related]
13. Association of dehydroepiandrosterone sulfate and testosterone deficiency with bone turnover in men with inflammatory bowel disease.
Szathmári M; Vásárhelyi B; Treszl A; Tulassay T; Tulassay Z
Int J Colorectal Dis; 2002 Mar; 17(2):63-6. PubMed ID: 12014422
[TBL] [Abstract][Full Text] [Related]
14. [Number of teeth and hormonal profile of postmenopausal women with osteoporosis, osteopenia and normal bone mineral density--a preliminary study].
Stagraczyński M; Kulczyk T; Leszczyński P; Męczekalski B
Pol Merkur Lekarski; 2015 Oct; 39(232):214-8. PubMed ID: 26608487
[TBL] [Abstract][Full Text] [Related]
15. [Reduced serum dehydroepiandrosterone levels in postmenopausal osteoporosis].
Fingerová H; Matlochová J
Ceska Gynekol; 1998 Apr; 63(2):110-3. PubMed ID: 9650403
[TBL] [Abstract][Full Text] [Related]
16. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age.
Guazzo EP; Kirkpatrick PJ; Goodyer IM; Shiers HM; Herbert J
J Clin Endocrinol Metab; 1996 Nov; 81(11):3951-60. PubMed ID: 8923843
[TBL] [Abstract][Full Text] [Related]
17. Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women's Health Study.
Johannes CB; Stellato RK; Feldman HA; Longcope C; McKinlay JB
J Clin Epidemiol; 1999 Feb; 52(2):95-103. PubMed ID: 10201649
[TBL] [Abstract][Full Text] [Related]
18. CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulfate level, and bone mineral density in postmenopausal women.
Bácsi K; Kósa JP; Borgulya G; Balla B; Lazáry A; Nagy Z; Horváth C; Speer G; Lakatos P
Calcif Tissue Int; 2007 Mar; 80(3):154-9. PubMed ID: 17334880
[TBL] [Abstract][Full Text] [Related]
19. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
20. Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial.
von Mühlen D; Laughlin GA; Kritz-Silverstein D; Bergstrom J; Bettencourt R
Osteoporos Int; 2008 May; 19(5):699-707. PubMed ID: 18084691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
